Showing results (2391-2400 of 2,546) with videos related to

Sort By:
Pageof 255
Leukemia|March 2, 2012
Outcome of patients activating an unrelated donor search: the impact of transplant with reduced intensity conditioning in a large cohort of consecutive high-risk patientsA Rambaldi, A Bacigalupo, R Fanin, et al.
Leukemia|February 19, 2013
Chronic fatigue is the most important factor limiting health-related quality of life of chronic myeloid leukemia patients treated with imatinibF Efficace, M Baccarani, M Breccia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2020
A Randomized Placebo Controlled Phase II Trial Evaluating Exemestane with or without Enzalutamide in Patients with Hormone Receptor-Positive Breast CancerIan Krop, Vandana Abramson, Marco Colleoni, et al.
Leukemia|May 3, 2016
PML-RARα kinetics and impact of FLT3-ITD mutations in newly diagnosed acute promyelocytic leukaemia treated with ATRA and ATO or ATRA and chemotherapyL Cicconi, M Divona, C Ciardi, et al.
Blood|March 1, 2023
Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agentsMichael A Spinner, R A Sica, John S Tamaresis, et al.
Plos One|July 30, 2021
Development and validation of a prognostic 40-day mortality risk model among hospitalized patients with COVID-19Donald A Berry, Andrew Ip, Brett E Lewis, et al.
Haematologica|September 17, 2016
High-dose therapy and autologous stem cell transplantation in patients with POEMS syndrome: a retrospective study of the Plasma Cell Disorder sub-committee of the Chronic Malignancy Working Party of the European Society for Blood & Marrow TransplantationGordon Cook, Simona Iacobelli, Anja van Biezen, et al.
The Lancet. Oncology|June 9, 2019
Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trialJorge E Cortes, Samer Khaled, Giovanni Martinelli, et al.
Cell Reports|April 18, 2019
Lethal Poisoning of Cancer Cells by Respiratory Chain Inhibition plus Dimethyl α-KetoglutarateValentina Sica, Jose Manuel Bravo-San Pedro, Valentina Izzo, et al.
Leukemia|August 16, 2022
Chromothripsis is a frequent event and underlies typical genetic changes in early T-cell precursor lymphoblastic leukemia in adultsSilvia Arniani, Valentina Pierini, Fabrizia Pellanera, et al.
Pageof 255